ANTX Live signaler | Maksimer profitt med Getagraph.com

SELG 117048 min ago

@ $20.32

Utstedt: 8 feb 2024 @ 15:30

Avkastning: -88.33%

Forrige signal: feb 6 - 18:43

Forrige signal: Kjøp

Avkastning: 0.27 %

Live Chart Being Loaded With Signals

Commentary (29 apr 2024 @ 22:00):

AN2 Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing treatments for rare, chronic, and serious infectious diseases...

Stats
Dagens volum	67 468.00
Gjennomsnittsvolum	482 606
Markedsverdi	70.56M
EPS	$-0.650 ( 2023-11-09 )
Neste inntjeningsdato	( $-0.610 ) 2024-05-09
Last Dividend	$0.656 ( 2018-01-11 )
Next Dividend	$0 ( N/A )
P/E	-0.860
ATR14	$0.00600 (0.25%)

Insider Trading

Date	Person	Action	Amount	type
2024-03-15	Eckburg Paul	Buy	30 000	Common Stock
2024-03-15	Day Lucy	Buy	55 000	Stock Option (right to buy)
2024-03-15	Day Lucy	Buy	27 500	Common Stock
2024-03-15	Eizen Joshua M	Buy	60 000	Stock Option (right to buy)
2024-03-15	Eizen Joshua M	Buy	30 000	Common Stock

INSIDER POWER
65.44
Last 100 transactions
Buy: 3 449 514 \| Sell: 642 134

Volum Korrelasjon

Lang: 0.22 (neutral)

Kort: 0.09 (neutral)

Signal:(34.647) Neutral

Anthem Inc. Corporate Korrelasjon

10 Mest positive korrelasjoner
SFL	0.949
MIC	0.937
X	0.923
APO-PA	0.921
FLSP	0.92
UBS	0.912
CEIX	0.907
PSN	0.903
CXW	0.901
HRB	0.898

10 Mest negative korrelasjoner
HE	-0.92
ENIA	-0.915
AGTI	-0.909
RMD	-0.906
SFUN	-0.903
FNA	-0.899
NWE	-0.899
K	-0.898
HIPO	-0.89
NUV	-0.888

Visste du det?

Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).

Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.

Anthem Inc. Corporate Korrelasjon - Valuta/Råvare

0.37
( neutral )

0.83
( strong )

0.00
( neutral )

0.82
( strong )

0.88
( strong )

-0.81
( strong negative )

Anthem Inc. Corporate Økonomi

Annual	2023
Omsetning:	$0
Bruttogevinst:	$0 (0.00 %)
EPS:	$-2.74

FY	2023
Omsetning:	$0
Bruttogevinst:	$0 (0.00 %)
EPS:	$-2.74

FY	2022
Omsetning:	$0
Bruttogevinst:	$-77 000.00 (0.00 %)
EPS:	$-2.14

FY	2021
Omsetning:	$0.00
Bruttogevinst:	$0.00 (0.00 %)
EPS:	$-1.534

Financial Reports:

No articles found.

Anthem Inc. Corporate Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)

Anthem Inc. Corporate Dividend Information - Ex Dividend Junior

Dividend Sustainability Score: 0 - N/A | Divividend Growth Potential Score: 0 - N/A

Information

First Dividend	$0.576	2015-07-13
Last Dividend	$0.656	2018-01-11
Next Dividend	$0	N/A
Payout Date	0000-00-00
Next Payout Date	N/A
# dividends	11	--
Total Paid Out	$7.14	--
Avg. Dividend % Per Year	0.00%	--
Score	1.61	--
Div. Sustainability Score	0
Div.Growth Potential Score	0
Div. Directional Score	0	--

Next Divdend (Est)
(2024-06-24)

$0 Estimate 0.00 %

Dividend Stability

0.07 Very Bad

Dividend Score

1.61

Pay Frequency

Quarterly

Yearly Payout

Year	Amount	Yield
2015	$0	0.00%
2016	$0	0.00%
2017	$0	0.00%
2018	$0.656	1.15%
2019	$0	0.00%
2020	$0	0.00%
2021	$0	0.00%
2022	$0	0.00%
2023	$0	0.00%
2024	$0	0.00%

Dividend Commentary

Unable to generate commentary due to missing data.

Top 10 dividend Companies for NYSE

Symbol	Title	Last dividend	Frequency	Years Dividend	Yearly Dividend	Score
LOMA	Dividend Knight	2023-06-30	Quarterly	2	5.23%	8.53
NCV	Dividend Royal	2024-02-09	Monthly	22	7.68%	8.50
MTR	Dividend Diamond	2023-10-30	Monthly	39	10.10%	8.50
SBR	Dividend Royal	2023-11-14	Monthly	38	7.74%	8.50
PDI	Dividend Royal	2023-11-10	Monthly	13	7.86%	8.50
ZTR	Dividend King	2024-02-09	Monthly	37	8.35%	8.50
ORC	Dividend Royal	2023-11-29	Monthly	12	9.23%	8.50
KIO	Dividend Royal	2023-12-14	Monthly	12	7.05%	8.50
NCZ	Dividend Royal	2024-02-09	Monthly	22	7.79%	8.50
SCM	Dividend King	2023-12-15	Monthly	13	7.08%	8.50

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	0	1.500	0	0	[0 - 0.5]
returnOnAssetsTTM	-0.461	1.200	-10.00	-10.00	[0 - 0.3]
returnOnEquityTTM	-0.590	1.500	-7.67	-10.00	[0.1 - 1]
payoutRatioTTM	0	-1.000	0	0	[0 - 1]
currentRatioTTM	7.87	0.800	10.00	8.00	[1 - 3]
quickRatioTTM	7.74	0.800	10.00	8.00	[0.8 - 2.5]
cashRatioTTM	1.114	1.500	4.92	7.38	[0.2 - 2]
debtRatioTTM	0	-1.500	0	0	[0 - 0.6]
interestCoverageTTM	97.26	1.000	10.00	10.00	[3 - 30]
operatingCashFlowPerShareTTM	-1.792	2.00	-0.597	-1.195	[0 - 30]
freeCashFlowPerShareTTM	-1.792	2.00	-0.896	-1.792	[0 - 20]
debtEquityRatioTTM	0	-1.500	0	0	[0 - 2.5]
grossProfitMarginTTM	0	1.000	-3.33	-3.33	[0.2 - 0.8]
operatingProfitMarginTTM	0	1.000	-2.00	-2.00	[0.1 - 0.6]
cashFlowToDebtRatioTTM	0	1.000	-1.111	-1.111	[0.2 - 2]
assetTurnoverTTM	0	0.800	-3.33	-2.67	[0.5 - 2]
Total Score				-0.272

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	-1.078	1.000	-0.210	0	[1 - 100]
returnOnEquityTTM	-0.590	2.50	-4.93	-10.00	[0.1 - 1.5]
freeCashFlowPerShareTTM	-1.792	2.00	-0.597	-1.792	[0 - 30]
dividendYielPercentageTTM	0	1.500	0	0	[0 - 0.4]
operatingCashFlowPerShareTTM	-1.792	2.00	-0.597	-1.195	[0 - 30]
payoutRatioTTM	0	1.500	0	0	[0 - 1]
pegRatioTTM	0	1.500	-3.33	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0	1.000	-2.50	0	[0.1 - 0.5]
Total Score				-1.510

Anthem Inc. Corporate

AN2 Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing treatments for rare, chronic, and serious infectious diseases. It is developing epetraborole, a once-daily oral treatment for patients with chronic non-tuberculous mycobacterial lung disease. The company was incorporated in 2017 and is headquartered in Menlo Park, California.